BlackRock, Inc. 13D and 13G filings for Utah Medical Products, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-07-17 8:12 pm Purchase | 2025-06-30 | 13G | UTAH MEDICAL PRODUCTS INC UTMD | BlackRock Inc. BLK | 172,684 5.300% | 4,070 (+2.41%) | Filing |
| 2025-02-05 1:23 pm Sale | 2024-12-31 | 13G | UTAH MEDICAL PRODUCTS INC UTMD | BlackRock Inc. BLK | 168,614 4.970% | -35,807 (-17.52%) | Filing |
| 2024-01-29 5:25 pm Sale | 2023-12-31 | 13G | UTAH MEDICAL PRODUCTS INC UTMD | BlackRock Inc. BLK | 204,421 5.600% | -1,093 (-0.53%) | Filing |
| 2023-02-01 4:54 pm Sale | 2022-12-31 | 13G | UTAH MEDICAL PRODUCTS INC UTMD | BlackRock Inc. BLK | 205,514 5.700% | -11,493 (-5.30%) | Filing |
| 2022-01-31 5:49 pm Sale | 2021-12-31 | 13G | UTAH MEDICAL PRODUCTS INC UTMD | BlackRock Inc. BLK | 217,007 5.900% | -5,682 (-2.55%) | Filing |